Searching for Early Detection Biomarkers of Nasopharyngeal Carcinoma in Zhongshan City
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Diagnostic test, Biological
Study Type: Observational
SUMMARY
All participants will be tested for EBV associated biomarkers, including EBNA1-IgA, VCA-IgA, BNLF2b total antibodies (P85-Ab) et al. For all male participants and P85-Ab positive female participants, EBV DNA in plasma will be tested. Screening positive participants will be followed up annually. All subjects will also be followed by record linkage to Cancer Register and Population Register.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 30
Maximum Age: 69
Healthy Volunteers: t
View:
• Subject residents in Zhongshan City or Wuzhou City
• Subject has no medical record of nasopharyngeal carcinoma
• ECOG 0-2
• Subject is able to comprehend, sign, and date the written informed consent document to participate in the study.
• Subject has psychical condition and well consciousness, and also accept and cooperate with the follow-up of this study.
Locations
Other Locations
China
Wuzhou Red Cross Hospital
RECRUITING
Wuzhou
Zhongshan People's Hospital
RECRUITING
Zhongshan
Contact Information
Primary
Mingfang Ji, MD
jmftbh@sina.com
86-760-89880417
Time Frame
Start Date: 2020-04-01
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 40000
Treatments
Screening cohort
30-69 years old healthy participants in Zhongshan and Wuzhou.
Authors
Related Therapeutic Areas
Sponsors
Collaborators: Wuzhou Red Cross Hospital, Xiamen University
Leads: Zhongshan People's Hospital, Guangdong, China